Related Experiment Video
Updated: Nov 22, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
Potential effective inhibitory compounds against Prostate Specific Membrane Antigen (PSMA): A molecular docking and
Zahra Nikfarjam1, Omid Bavi2, Saeed K Amini1
1Department of Physical & Computational Chemistry, Chemistry and Chemical Engineering Research Center of Iran, Tehran, 1496813151, Iran.
Researchers identified novel compounds to inhibit Prostate-Specific Membrane Antigen (PSMA) in prostate cancer. Computational methods screened natural compounds, revealing four potent inhibitors with potential for new cancer therapies.
Area of Science:
- Biochemistry
- Computational Chemistry
- Oncology
Background:
- Prostate cancer is a leading cancer in men.
- Prostate-Specific Membrane Antigen (PSMA) is a key target for cancer therapy.
- Developing novel inhibitors is crucial for effective treatment.
Purpose of the Study:
- To identify natural compounds that can suppress Prostate-Specific Membrane Antigen (PSMA) protein.
- To computationally screen and evaluate potential PSMA inhibitors.
- To design more effective inhibitors for prostate cancer treatment.
Main Methods:
- Pharmacophore and ADMET analysis of natural compounds from the ZINC database.
- Molecular docking and molecular dynamics simulations to assess ligand-protein interactions.
- MMPBSA/GBSA analysis to determine binding free energies and inhibition potential.
Main Results:
- Four compounds (Z10, Z06, Z01, Z03) showed significant interactions with PSMA active site residues.
- Binding free energies of selected compounds were comparable to the reference ligand.
- Analysis revealed critical interactions within the S1/S1' pockets, guiding inhibitor design.
Conclusions:
- Identified potent small molecules as potential inhibitors of PSMA.
- Computational approaches successfully guided the discovery of effective PSMA inhibitors.
- These findings pave the way for developing novel immunotoxins and antibody treatments for prostate cancer.
More Related Videos
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025